Renaissance Technologies LLC Acquires 4,900 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Renaissance Technologies LLC grew its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 5.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 91,923 shares of the company's stock after acquiring an additional 4,900 shares during the period. Renaissance Technologies LLC owned 0.61% of U.S. Physical Therapy worth $8,154,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. State Street Corp boosted its stake in shares of U.S. Physical Therapy by 17.5% during the 3rd quarter. State Street Corp now owns 667,868 shares of the company's stock worth $56,522,000 after acquiring an additional 99,244 shares in the last quarter. Wells Fargo & Company MN boosted its position in U.S. Physical Therapy by 2.2% during the fourth quarter. Wells Fargo & Company MN now owns 112,959 shares of the company's stock worth $10,021,000 after purchasing an additional 2,465 shares during the period. Geode Capital Management LLC grew its holdings in U.S. Physical Therapy by 1.3% during the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company's stock valued at $29,040,000 after purchasing an additional 4,477 shares during the last quarter. HighTower Advisors LLC lifted its stake in shares of U.S. Physical Therapy by 13.6% in the third quarter. HighTower Advisors LLC now owns 4,714 shares of the company's stock worth $399,000 after buying an additional 566 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of U.S. Physical Therapy by 37.4% during the 4th quarter. PNC Financial Services Group Inc. now owns 4,605 shares of the company's stock worth $409,000 after buying an additional 1,254 shares during the period.

U.S. Physical Therapy Stock Performance

Shares of USPH traded up $0.53 on Tuesday, reaching $66.84. 30,842 shares of the stock traded hands, compared to its average volume of 106,508. The stock's 50-day moving average price is $76.06 and its 200-day moving average price is $84.71. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The firm has a market cap of $1.02 billion, a price-to-earnings ratio of 71.10, a P/E/G ratio of 3.54 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 12 month low of $62.77 and a 12 month high of $108.14.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. Equities analysts forecast that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 14th were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.69%. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Friday, March 14th. U.S. Physical Therapy's payout ratio is presently 97.83%.

Analysts Set New Price Targets

USPH has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. decreased their price target on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Wednesday, March 19th. William Blair reaffirmed a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Barrington Research cut their price target on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. StockNews.com downgraded shares of U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Thursday, April 17th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $113.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, U.S. Physical Therapy has an average rating of "Moderate Buy" and an average target price of $109.00.

Insider Activity

In related news, COO Graham D. Reeve sold 1,730 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at $588,564.48. This trade represents a 19.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 1.70% of the company's stock.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.